Literature DB >> 22520462

Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.

Ulrich Meinzer1, Frederick Barreau, Sophie Esmiol-Welterlin, Camille Jung, Claude Villard, Thibaut Léger, Sanah Ben-Mkaddem, Dominique Berrebi, Monique Dussaillant, Ziad Alnabhani, Maryline Roy, Stéphane Bonacorsi, Hans Wolf-Watz, Julie Perroy, Vincent Ollendorff, Jean-Pierre Hugot.   

Abstract

Yersinia pseudotuberculosis is an enteropathogenic bacteria that disrupts the intestinal barrier and invades its host through gut-associated lymphoid tissue and Peyer's patches (PP). We show that the Y. pseudotuberculosis effector YopJ induces intestinal barrier dysfunction by subverting signaling of the innate immune receptor Nod2, a phenotype that can be reversed by pretreating with the Nod2 ligand muramyl-dipeptide. YopJ, but not the catalytically inactive mutant YopJ(C172A), acetylates critical sites in the activation loops of the RICK and TAK1 kinases, which are central mediators of Nod2 signaling, and decreases the affinity of Nod2 for RICK. Concomitantly, Nod2 interacts with and activates caspase-1, resulting in increased levels of IL-1β. Finally, IL-1β within PP plays an essential role in inducing intestinal barrier dysfunction. Thus, YopJ alters intestinal permeability and promotes the dissemination of Yersinia as well as commensal bacteria by exploiting the mucosal inflammatory response.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22520462     DOI: 10.1016/j.chom.2012.02.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  57 in total

Review 1.  Cyclic dinucleotides and the innate immune response.

Authors:  Olga Danilchanka; John J Mekalanos
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 2.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

3.  The Arabidopsis ZED1 pseudokinase is required for ZAR1-mediated immunity induced by the Pseudomonas syringae type III effector HopZ1a.

Authors:  Jennifer D Lewis; Amy Huei-Yi Lee; Jana A Hassan; Janet Wan; Brenden Hurley; Jacquelyn R Jhingree; Pauline W Wang; Timothy Lo; Ji-Young Youn; David S Guttman; Darrell Desveaux
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

4.  Which Environmental Factors Cause IBD Relapses?

Authors:  Franck Carbonnel; Jean Pierre Hugot
Journal:  Dig Dis Sci       Date:  2015-02-14       Impact factor: 3.199

Review 5.  YopJ Family Effectors Promote Bacterial Infection through a Unique Acetyltransferase Activity.

Authors:  Ka-Wai Ma; Wenbo Ma
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

6.  Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling.

Authors:  Nicholas Paquette; Joseph Conlon; Charles Sweet; Florentina Rus; Lindsay Wilson; Andrea Pereira; Charles V Rosadini; Nadege Goutagny; Alexander N R Weber; William S Lane; Scott A Shaffer; Stephanie Maniatis; Katherine A Fitzgerald; Lynda Stuart; Neal Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 7.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

8.  RIP2 promotes FcγR-mediated reactive oxygen species production.

Authors:  Michael G Shehat; Omar A Cardona; George F Aranjuez; Mollie W Jewett; Justine T Tigno-Aranjuez
Journal:  J Biol Chem       Date:  2019-05-21       Impact factor: 5.157

Review 9.  Yersinia type III effectors perturb host innate immune responses.

Authors:  Khavong Pha; Lorena Navarro
Journal:  World J Biol Chem       Date:  2016-02-26

Review 10.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.